Physician profile
Vincent Samuel
NPI 1467428177
$2,192.57
in general payments reported to CMS, 2019-2025
11 companies · $1,071 in 2025
The $1,071 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $432 · 2021: $53.20 · 2022: $54.34 · 2023: $22.10 · 2024: $82.05 · 2025: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.91 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $897.06 | 2025 | Intellis Adaptivestim, Inceptiv, Osteocool Rf Ablation System |
| Merck Sharp & Dohme LLC | $275.99 | 2019-2024 | Bridion |
| Mallinckrodt Hospital Products INC. | $232.45 | 2020 | |
| Avanos Medical | $190.64 | 2020-2022 | |
| Novo Nordisk INC | $145.13 | 2024-2025 | Wegovy |
| Mallinckrodt Enterprises LLC | $104.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $84.30 | 2019 | |
| Edwards Lifesciences Corporation | $82.23 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.66 | 2025 | |
| Portola Pharmaceuticals, LLC | $58.51 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $43.47 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.